Abstract:
The present disclosure relates to anti-IgE antibodies that bind to novel antigenic epitopes of the CsmX domain, e.g., SVPHPRCHCGAGRA (SEQ ID NO:4) and the uses thereof in treating IgE-mediated diseases.
Abstract translation:本公开涉及结合CsmX结构域的新型抗原表位(例如SVPHPRCHCGAGRA(SEQ ID NO:4))的抗IgE抗体及其在治疗IgE介导的疾病中的用途。
Abstract:
The present disclosure relates to anti-IgE antibodies that bind to novel antigenic epitopes of the CsmX domain, e.g., SVPHPRCHCGAGRA (SEQ ID NO: 4) and the uses thereof in treating IgE-mediated diseases.